2BB score and signals
Arcutis Biotherapeutics, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 56 | Moderate |
| Momentum | 36 | Weakening |
| Financial strength | 65 | Strong |
| Quality | 99 | Very Strong |
| Risk | 27 | Low |
Company facts
| CEO | Frank Watanabe |
| Headquarters | Westlake Village, California, United States |
| Founded | 2016 |
| Employees | 354 |
| P/E ratio | 123.12 |
| 52-week range | $19.30 – $31.77 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-23 | — | 0.2436 | — | $163.35M |
| 2026-10-29 | — | 0.1753 | — | $144.52M |
| 2026-08-05 | — | 0.0439 | — | $121.23M |
| 2026-05-06 | -0.09 | -0.0838 | $105.40M | $103.29M |
Related companies
2BBBullish & Bearish